Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation
Radhika Goenka, Andrew H. Matthews, Bochao Zhang, Patrick J. O'Neill, Jean L. Scholz, Thi-Sau Migone, Warren J. Leonard, William Stohl, Uri Hershberg and Michael P. Cancro
The Journal of experimental medicine, v 211(1), pp 45-56
Immunology Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine Science & Technology
We have assessed the role of B lymphocyte stimulator (BLyS) and its receptors in the germinal center (GC) reaction and affinity maturation. Despite ample BLyS retention on B cells in follicular (FO) regions, the GC microenvironment lacks substantial BLyS. This reflects IL-21-mediated down-regulation of the BLyS receptor TACI (transmembrane activator and calcium modulator and cyclophilin ligand interactor) on GC B cells, thus limiting their capacity for BLyS binding and retention. Within the GC, FO helper T cells (TFH cells) provide a local source of BLyS. Whereas T cell-derived BLyS is dispensable for normal GC cellularity and somatic hypermutation, it is required for the efficient selection of high affinity GC B cell clones. These findings suggest that during affinity maturation, high affinity clones rely on TFH-derived BLyS for their persistence.
Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation
Creators
Radhika Goenka - University of Pennsylvania
Andrew H. Matthews - University of Pennsylvania
Bochao Zhang - Drexel University
Patrick J. O'Neill - University of Pennsylvania
Jean L. Scholz - University of Pennsylvania
Thi-Sau Migone - Human Genome Sciences
Warren J. Leonard - National Heart Lung and Blood Institute
William Stohl - University of Southern California
Uri Hershberg - Drexel University
Michael P. Cancro - University of Pennsylvania
Publication Details
The Journal of experimental medicine, v 211(1), pp 45-56
Publisher
Rockefeller Univ Press
Number of pages
12
Grant note
ZIAHL005408 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
Human Genome Sciences, Inc.
P30CA016520 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
AI073939; AR050193 / National Institutes of Health [NIH]; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
R01AR050193 / NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)
Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
R01AI073939 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Resource Type
Journal article
Language
English
Academic Unit
School of Biomedical Engineering, Science, and Health Systems
Web of Science ID
WOS:000329793300005
Scopus ID
2-s2.0-84892546134
Other Identifier
991019167434704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: